Improving Breast Cancer Diagnosis and Treatment

Currently, across Canada, routine diagnostic testing of the patient’s tumour focuses on known or existing breast cancer markers. Funding for broader accurate molecular testing to assess the tumour is not routinely available.
There is limited access to molecular information in the context of treatment. Patients have less opportunity to enroll in cutting-edge clinical trials and development of novel targeted therapies is delayed.
The opportunities to improve breast cancer diagnosis and treatment are greater than ever before. With the support of our donors, we operationalize research and deliver real, measurable results to patients across Canada.

Five-Year Research Plan

The BCSC Pan-Canadian Virtual Research Laboratory gives patients access to advanced molecular testing so they will have opportunities to enroll in clinical trials which test targeted therapeutic agents based on a particular genetic mutation.

The BCSC research approach is innovative because of its clinical interface – it is translational – focusing on rapid movement of research findings from bench to bedside. Our mandate to researchers will be to improve patient outcomes and accelerate the delivery of and access to novel therapies.

This is an avant-garde approach to breast cancer research in Canada. Making data available to researchers across the country will lead to a new way of thinking and will contribute to building the knowledge base required to find the cure for breast cancer.

We are disrupting how breast cancer research is conducted in Canada. Our researchers will be rewarded for improving patient outcomes; driving research from the lab directly to the clinic, not for publishing their work in scientific research journals.

Research Milestones

Close Menu